Feature

Health sector has spent $464 million on lobbying in 2020


 

The Pharmaceutical Research and Manufacturers of America led the health sector in spending on lobbying through the first three quarters of 2020, and health care as a whole spent more than any of the other 12 sectors of the U.S. economy, according to the Center for Responsive Politics.

Highest-spending lobbyers through third quarter, 2020

PhRMA spent $20.7 million on lobbying through the end of September, good enough for third on the overall list of U.S. companies and organizations. Three other members of the health sector made the top 10: the American Hospital Association ($18.3 million), BlueCross/BlueShield ($16.3 million), and the American Medical Association ($15.2 million), the center reported.

Total spending by the health sector was $464 million from Jan. 1 to Sept. 30, topping the finance/insurance/real estate sector at $403 million, and miscellaneous business at $371 million. Miscellaneous business is the home of the U.S. Chamber of Commerce, the annual leader in such spending for the last 20 years, based on data from the Senate Office of Public Records.

The largest share of health sector spending came from pharmaceuticals/health products, with a total of almost $233 million, just slightly more than the sector’s four other constituents combined: hospitals/nursing homes ($80 million), health services/HMOs ($75 million), health professionals ($67 million), and miscellaneous health ($9.5 million), the center said on OpenSecrets.org.

Taking one step down from the sector level, that $233 million made pharmaceuticals/health products the highest spending of about 100 industries in 2020, nearly doubling the efforts of electronics manufacturing and equipment ($118 million), which came a distant second. Hospitals/nursing homes was eighth on the industry list, the center noted.

Recommended Reading

A young physician hopes to buck the status quo in Congress
Federal Practitioner
More female specialists, but gender gap persists in pay, survey finds
Federal Practitioner
Revamping mentorship in medicine
Federal Practitioner
Pandemic poses new challenges for rural doctors
Federal Practitioner
Access to care: A nurse practitioner’s plea
Federal Practitioner
Mastering mask communicating
Federal Practitioner
Outpatient visits rebound for most specialties to pre-COVID-19 levels
Federal Practitioner
Popularity of virtual conferences may mean a permanent shift
Federal Practitioner
Chinese American families suffer discrimination related to COVID-19
Federal Practitioner
HHS extends deadline for patient access to your clinical notes
Federal Practitioner